Aurobindo Pharma reports marginal rise in Q2 consolidated net profit

06 Nov 2025 Evaluate

Aurobindo Pharma has reported result for second quarter ended September 30, 2025 (Q2FY26).

The company has reported 8.16% rise in its net profit at Rs 581.37 crore for the quarter ended September 30, 2025 as compared to Rs 537.53 crore for the same quarter in the previous year. The total income of the company increased by 0.07% at Rs 2,949.24 crore for Q2FY26 as compared to Rs 2,947.25 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 3.80% rise in its net profit at Rs 848.45 crore for Q2FY26 as compared to Rs 817.38 crore for the same quarter in the previous year. The total income of the company increased by 5.98% at Rs 8,406.29 crore for Q2FY26 as compared to Rs 7,932.07 crore for the corresponding quarter previous year.

Aurobindo Pharma Share Price

1205.95 -6.70 (-0.55%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×